← Open Payments lookup

AMANDA BONE: Open Payments

NPI 1205609518 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$702 in 35 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $667 · 2025 $702

Food & beverage: $702
CompanyPaymentsAmount
Gilead Sciences, Inc.9$154
ABBVIE INC.7$143
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$67
PFIZER INC.3$57
Takeda Pharmaceuticals U.S.A., Inc.2$50
Lilly USA, LLC2$50
Ipsen Biopharmaceuticals, Inc2$49
GENZYME CORPORATION2$31
Intercept Pharmaceuticals, Inc.1$24
QOL Medical, LLC1$24

Products named: XIFAXAN, CREON, ENTYVIO, IQIRVO, VELSIPITY, DUPIXENT, VIBERZI, OCALIVA.

Industry payments across PA — which companies pay providers there.